nlrp3 ko mice (Jackson Laboratory)
Structured Review

Nlrp3 Ko Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nlrp3+ko+mice/pmc13156568-42-0-8?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway"
Article Title: Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway
Journal: iScience
doi: 10.1016/j.isci.2026.115779
Figure Legend Snippet: Propranolol suppressed NLRP3 inflammasome activation in tMCAO mice (A) Western blot analysis of IBA-1, NLRP3, and IL-1β in the ischemic penumbra of different groups. (B–D) Quantitative analysis of IBA-1, NLRP3, and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus the Sham-operated group; # p < 0.05 versus the tMCAO group. (E) Immunofluorescence staining for NLRP3 of brain sections in the indicated groups. Scale bars, 100 μm (main image) and 30 μm (magnified view). (F) Quantitative analysis of NLRP3 positive cells ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗∗ p < 0.001 versus the Sham-operated group; # p < 0.05 versus the tMCAO group. (G) Immunofluorescence staining for IBA-1 of brain sections in the indicated groups. Scale bars, 50 μm (main image) and 10 μm (magnified view). (H) Representative images of microglia and heat maps of Sholl analysis were shown. Scale bar, 10 μm. (I) Sholl profile shows the number of intersections at different distances from the microglial soma in the indicated groups ( n = 4 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using two-way ANOVA followed by Tukey’s post hoc test. ∗∗∗∗ p < 0.0001 versus the Sham-operated group; #### p < 0.0001 versus the tMCAO group. (J and K) Quantitative analysis of process length (J) and endpoints (K) per cell ( n = 4 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗∗ p < 0.001 versus the Sham-operated group; # p < 0.05and ## p < 0.01 versus the tMCAO group.
Techniques Used: Activation Assay, Western Blot, Expressing, Immunofluorescence, Staining
Figure Legend Snippet: NLRP3 -/- mice exhibited reduced cerebral infarction volume and attenuated BBB damage (A) TTC staining was performed to measure the cerebral infarct volume in mice. Scale bar, 5 mm. (B) Statistical analysis of infarction volume in different groups ( n = 6 mice/group). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ## p < 0.01 versus the WT tMCAO group; ns, not significant. (C) Neurological function evaluation was conducted using the mNSS score ( n = 8 mice/group). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. # p < 0.05 versus the WT tMCAO group; ns, not significant. (D) Western blot analysis of NLRP3, IL-1β, Occludin, and ZO-1 in the ischemic penumbra of different groups. (E) Quantitative analysis of NLRP3, IL-1β, Occludin, and ZO-1 expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 versus the WT Sham-operated group; # p < 0.05, ## p < 0.01, and #### p < 0.0001 versus the WT tMCAO group; ns, not significant. (F) Representative images of brain slices show the extravasation of EB. Scale bar, 5 mm. (G) Quantitative analysis of EB leakage in mice from different groups ( n = 4 mice/group). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. # p < 0.05 versus the WT tMCAO group; ns, not significant.
Techniques Used: Staining, Western Blot, Expressing
Figure Legend Snippet: Knockout of NLRP3 alleviated BBB damage and the activation of microglia caused by tMCAO (A) Immunofluorescence staining for IBA-1 of brain sections in the indicated groups. Scale bars, 50 μm (main image) and 10 μm (magnified view). (B) Representative images of microglia and heat maps of Sholl analysis were shown. Scale bar, 10 μm. (C) Sholl profile shows the number of intersections at different distances from the microglial soma in the indicated groups ( n = 4 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using two-way ANOVA followed by Tukey’s post hoc test. ∗∗∗∗ p < 0.0001 versus the WT Sham-operated group; #### p < 0.0001 versus the WT tMCAO group. (D and E) Quantitative analysis of process length (D) and endpoints (E) per cell ( n = 4 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗∗ p < 0.001 versus the WT Sham-operated group; # p < 0.05 versus the WT tMCAO group; ns, not significant. (F) Immunofluorescence staining for CD-31 of brain sections of the indicated groups. Scale bars, 100 μm (main image) and 30 μm (magnified view). (G) Statistical analysis of CD-31 positive cells ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗∗ p < 0.001 versus the WT Sham-operated group; # p < 0.05 versus the WT tMCAO group; ns, not significant.
Techniques Used: Knock-Out, Activation Assay, Immunofluorescence, Staining
Figure Legend Snippet: Propranolol reduced the expression of NLRP3 and IL-1β in BV2 cells subjected to OGD/R (A) Schematic of cell experiment steps. (B) Western blot analysis of NLRP3 and IL-1β in BV2 cells at 4, 6, 8, 12, and 24 h after OGD/R. (C and D) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 versus the control group. (E) Western blot analysis of NLRP3 and IL-1β in BV2 cells of different treatment groups. (F and G) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.
Techniques Used: Expressing, Western Blot, Control
Figure Legend Snippet: Blockade of β2-AR reduced the expression of NLRP3 in BV2 cells subjected to OGD/R (A) Western blot analysis of the effects of dobutamine and betaxolol on NLRP3 and IL-1β expression in BV2 cells. (B and C) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗∗ p < 0.001 versus the control group. (D) Western blot analysis of salmeterol and ICI118,551 on NLRP3 and IL-1β expression in BV2 cells. (E and F) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.
Techniques Used: Expressing, Western Blot, Control
Figure Legend Snippet: Activation of β2-AR induced the expression of NLRP3 and IL-1β via the ERK1/2 MAPK signaling pathway (A) Western blot analysis of the effects of H-89 and U0126 on NLRP3 and IL-1β expression in BV2 cells. (B and C) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 versus the OGD/R group. (D) Western blot analysis of p -ERK1/2 expression in BV2 cells. (E) Quantitative analysis of p -ERK1/2 expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 versus the OGD/R group.
Techniques Used: Activation Assay, Expressing, Western Blot, Control




